fascinating article about drug pricing, including Herceptin

rainnyc

This long article from Propublica is worth the read. While the focus is on the pricing of prescription eye drops, there's a lot in here that's very relevant to the high prices of cancer medications, and the authors include a recent repackaging of Herceptin that increases the price for many patients (or their insurers).

https://www.propublica.org/article/drug-companies-...

Note: Propublica is a nonprofit devoted to long form investigative journalism. I have no connection to them, other than being really impressed by what they're doing. They often partner with other publications, i.e. NPR or various newspapers.

carmstr835

Interesting article, but I agree that it is probably dosing costs not volume of the dose. However, I believe there are ways to cut the per patient cost of these drugs by repackaging aftermarket. I suppose that is illegal in some way.